[
  {
    "ts": null,
    "headline": "Abbott (ABT) Stock Dips While Market Gains: Key Facts",
    "summary": "In the most recent trading session, Abbott (ABT) closed at $134.01, indicating a -1.19% shift from the previous trading day.",
    "url": "https://finnhub.io/api/news?id=e799180606e7f910e5b02a1bf73c742274c4db1ae2cb11ed3e681247b9de1f3a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750110603,
      "headline": "Abbott (ABT) Stock Dips While Market Gains: Key Facts",
      "id": 135314436,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "In the most recent trading session, Abbott (ABT) closed at $134.01, indicating a -1.19% shift from the previous trading day.",
      "url": "https://finnhub.io/api/news?id=e799180606e7f910e5b02a1bf73c742274c4db1ae2cb11ed3e681247b9de1f3a"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories stock outperforms competitors despite losses on the day",
    "summary": "Abbott Laboratories stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=8cc13ca0b235cb5f8450ff576a7139876a598e0222a1d75c3d7e5a3d1011a2ad",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750091520,
      "headline": "Abbott Laboratories stock outperforms competitors despite losses on the day",
      "id": 135330398,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=8cc13ca0b235cb5f8450ff576a7139876a598e0222a1d75c3d7e5a3d1011a2ad"
    }
  },
  {
    "ts": null,
    "headline": "Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings",
    "summary": "Investing.com -- Leerink Partners began coverage on three of the largest medical technology companies on Monday, assigning bullish ratings to Boston Scientific (NYSE:BSX) and Medtronic (NYSE:MDT), while taking a more neutral stance on Abbott Laboratories (NYSE:ABT)",
    "url": "https://finnhub.io/api/news?id=23605e9cd61dcb111341f78d1df09f0dc230b888f00719faf85effc3bc959576",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750082069,
      "headline": "Leerink starts coverage on Boston Scientific and Medtronic with bullish ratings",
      "id": 135302974,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Investing.com -- Leerink Partners began coverage on three of the largest medical technology companies on Monday, assigning bullish ratings to Boston Scientific (NYSE:BSX) and Medtronic (NYSE:MDT), while taking a more neutral stance on Abbott Laboratories (NYSE:ABT)",
      "url": "https://finnhub.io/api/news?id=23605e9cd61dcb111341f78d1df09f0dc230b888f00719faf85effc3bc959576"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions",
    "summary": "Abbott (NYSE: ABT) announced today that Health Canada has approved the company's i-STAT TBI test cartridge for use with whole blood, helping clinicians to assess suspected concussion at the patient's bedside and obtain lab-quality results in 15 minutes. Previously, the tests used to help assess mild traumatic brain injury (mTBI) were only authorized for use with plasma or serum, requiring samples to be sent to a lab for processing.",
    "url": "https://finnhub.io/api/news?id=9d77d39a369493c9b6d3a9de4cdb2093e24b72ca922ca64a8cdf7dcafd6f10c1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750075200,
      "headline": "Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions",
      "id": 135302975,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (NYSE: ABT) announced today that Health Canada has approved the company's i-STAT TBI test cartridge for use with whole blood, helping clinicians to assess suspected concussion at the patient's bedside and obtain lab-quality results in 15 minutes. Previously, the tests used to help assess mild traumatic brain injury (mTBI) were only authorized for use with plasma or serum, requiring samples to be sent to a lab for processing.",
      "url": "https://finnhub.io/api/news?id=9d77d39a369493c9b6d3a9de4cdb2093e24b72ca922ca64a8cdf7dcafd6f10c1"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Declares 406th Consecutive Quarterly Dividend",
    "summary": "ABBOTT PARK, Ill. - The board of directors of Abbott today declared a quarterly common dividend of 59 cents per share.This marks the 406th consecutive quarterly dividend to be paid by Abbott since...",
    "url": "https://finnhub.io/api/news?id=f0c8f10991952d98fc277402765e9ced95455dcfc4cfecbcad4a00b0f92d591c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750065447,
      "headline": "Abbott Declares 406th Consecutive Quarterly Dividend",
      "id": 135300803,
      "image": "",
      "related": "ABT",
      "source": "Finnhub",
      "summary": "ABBOTT PARK, Ill. - The board of directors of Abbott today declared a quarterly common dividend of 59 cents per share.This marks the 406th consecutive quarterly dividend to be paid by Abbott since...",
      "url": "https://finnhub.io/api/news?id=f0c8f10991952d98fc277402765e9ced95455dcfc4cfecbcad4a00b0f92d591c"
    }
  },
  {
    "ts": null,
    "headline": "1 Unpopular Stock that Should Get More Attention and 2 to Avoid",
    "summary": "Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.",
    "url": "https://finnhub.io/api/news?id=b2c6b0fcdca9670bcc699f4efc42645aa963b3eb3fe78908bf382a5474aa66dd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750049234,
      "headline": "1 Unpopular Stock that Should Get More Attention and 2 to Avoid",
      "id": 135301105,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.",
      "url": "https://finnhub.io/api/news?id=b2c6b0fcdca9670bcc699f4efc42645aa963b3eb3fe78908bf382a5474aa66dd"
    }
  }
]